Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 9 Issue: 3, February

Editorial [Hot Topic: Methods and Non-Cancer Applications of HDAC Inhibition (Guest Editor: Olaf Wiest)]

Volume:9   Issue: 3
Pp: 226-226
Olaf Wiest
DOI: 10.2174/156802609788085278
Published on: 01 March, 2012

Assays for Histone Deacetylases

Volume:9   Issue: 3
Pp: 227-234
Alexander-Thomas Hauser, Mira Jung and Manfred Jung
DOI: 10.2174/156802609788085269
Published on: 01 March, 2012

Novel Structural Insights into Class I and II Histone Deacetylases

Volume:9   Issue: 3
Pp: 235-240
Ralf Ficner
DOI: 10.2174/156802609788085304
Published on: 01 March, 2012

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

Volume:9   Issue: 3
Pp: 257-271
Norbert L. Wiech, Jed F. Fisher, Paul Helquist and Olaf Wiest
DOI: 10.2174/156802609788085241
Published on: 01 March, 2012

Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+

Volume:9   Issue: 3
Pp: 272-291
Dante Rotili, Giovanna Simonetti, Andrea Savarino, Anna T. Palamara, Anna R. Migliaccio and Antonello Mai
DOI: 10.2174/156802609788085296
Published on: 01 March, 2012

Targeting Histone Deacetylase Inhibitors for Anti-Malarial Therapy

Volume:9   Issue: 3
Pp: 292-308
Katherine T. Andrews, Thanh N. Tran, Nicole C. Wheatley and David P. Fairlie
DOI: 10.2174/156802609788085313
Published on: 01 March, 2012

Histone Deacetylase Inhibitors In Inflammatory Disease

Volume:9   Issue: 3
Pp: 309-319
Maria A. Halili, Melanie R. Andrews, Matthew J. Sweet and David P. Fairlie
DOI: 10.2174/156802609788085250
Published on: 01 March, 2012

Molecule of the Month

Volume:9   Issue: 3
Pp: 320-320
Craig W. Lindsley
DOI: 10.2174/1568026610909030320
Published on: 01 March, 2012